Marshall Edwards Inc.

	Current News News Archive


Wednesday, 08 September 2010		print
Marshall Edwards Reaches Agreement in Principle to Acquire Intellectual Property Portfolio from Novogen view full article >>>
Tuesday, 31 August 2010		print
Marshall Edwards to Host Conference Call on September 8, 2010 view full article >>>
Tuesday, 10 August 2010		print
Marshall Edwards Appoints Oncologist Christine White to Board of Directors view full article >>>
Thursday, 17 June 2010		print
Marshall Edwards Announces Additional Management Changes with Appointment of New Chief Financial Officer view full article >>>
Thursday, 03 June 2010		print
Marshall Edwards CEO to Present at Needham Healthcare Conference view full article >>>
Tuesday, 01 June 2010		print
Marshall Edwards Announces Final Results from Halted Phase 3 Clinical Trial of Phenoxodiol view full article >>>
Friday, 21 May 2010		print
Report on Phase II Clinical Study of Marshall Edwards' Phenoxodiol in Prostate Cancer to be Presented at ASCO view full article >>>
Thursday, 06 May 2010		print
Marshall Edwards Appoints CEO as a Director view full article >>>
Thursday, 29 April 2010		print
Marshall Edwards Announces Grants under Nasdaq Rule 5635 view full article >>>
Monday, 26 April 2010		print
Marshall Edwards Appoints New President and CEO view full article >>>

Contact Details

Marshall Edwards, Inc.
11975 El Camino Real
Suite 101
San Diego, CA 92130

T: (858) 792-6300

.	home : about us. : about phenoxodiol : the technology : newsroom : : how to invest : contact details : credits : email Marshall Edwards Inc. 2001 ©